Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care
December 20, 2024 12:00 ET | Source: Avextra Pharma GmbH News Release…
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute…
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute…
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…